• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

识别首发和超高危精神病患者整体功能结局预测的神经认知标志物。

Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.

机构信息

Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Department of Child Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

出版信息

Psychiatry Clin Neurosci. 2017 May;71(5):318-327. doi: 10.1111/pcn.12522.

DOI:10.1111/pcn.12522
PMID:28294477
Abstract

AIM

There is an increasing need for identifying neurocognitive predictors of global functional outcome in early psychosis toward optimizing an early intervention strategy.

METHODS

We conducted a longitudinal observational study to investigate an association between neurocognitive assessments at baseline and global functional outcome at an average of 1-year follow up. Participants included ultra-high-risk for psychosis (UHR) individuals who had not converted to psychosis during the follow-up period (UHR-NP) and those with first-episode psychosis (FEP). We evaluated neurocognition at baseline using the Brief Assessment of Cognition in Schizophrenia Japanese version, including Verbal Memory, Working Memory, Motor Speed, Verbal Fluency, Attention/Processing Speed, and Executive Function. We also assessed global functional outcome using the modified Global Assessment of Functioning (mGAF) scale both at baseline and after the follow-up period.

RESULTS

Thirty-four UHR-NP individuals (34/47, 72%) and 29 FEP individuals (29/36, 81%) completed assessment of neurocognitive function at baseline and functional outcome at follow up. In the UHR-NP group, Attention/Processing Speed was significantly associated with the mGAF score at follow up. In the FEP group, Executive Function was significantly associated with the average mGAF score during follow up.

CONCLUSION

Attention/Processing Speed and Executive Function at baseline may predict global functional outcome of early psychosis. These neurocognitive tests are easy to incorporate in clinical settings and, if replicated in independent samples, may be included in routine clinical assessments for prediction of functional outcome in early psychosis.

摘要

目的

在早期精神病中,需要越来越多地识别神经认知预测因子,以优化早期干预策略,从而实现整体功能结局。

方法

我们进行了一项纵向观察性研究,旨在调查基线时的神经认知评估与平均 1 年随访时的整体功能结局之间的关联。参与者包括未在随访期间转变为精神病的精神病超高风险(UHR)个体(UHR-NP)和首发精神病(FEP)个体。我们使用日本版Brief Assessment of Cognition in Schizophrenia 评估基线时的神经认知,包括言语记忆、工作记忆、运动速度、言语流畅性、注意力/处理速度和执行功能。我们还在基线和随访后使用改良的全球功能评估(mGAF)量表评估整体功能结局。

结果

34 名 UHR-NP 个体(34/47,72%)和 29 名 FEP 个体(29/36,81%)完成了基线时的神经认知功能评估和随访时的功能结局评估。在 UHR-NP 组中,注意力/处理速度与随访时的 mGAF 评分显著相关。在 FEP 组中,执行功能与随访期间的平均 mGAF 评分显著相关。

结论

基线时的注意力/处理速度和执行功能可能预测早期精神病的整体功能结局。这些神经认知测试易于在临床环境中实施,如果在独立样本中得到验证,可能会被纳入早期精神病的常规临床评估中,以预测功能结局。

相似文献

1
Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.识别首发和超高危精神病患者整体功能结局预测的神经认知标志物。
Psychiatry Clin Neurosci. 2017 May;71(5):318-327. doi: 10.1111/pcn.12522.
2
Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?超高危精神病个体的神经认知障碍:谁会真正转化?
Aust N Z J Psychiatry. 2015 May;49(5):462-70. doi: 10.1177/0004867414561527. Epub 2014 Nov 25.
3
Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis.神经认知预测因素对精神病超高危人群识别后 2 至 13 年的功能结局的影响。
Schizophr Res. 2011 Oct;132(1):1-7. doi: 10.1016/j.schres.2011.06.014. Epub 2011 Jul 16.
4
Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.神经认知作为向精神病障碍和超高风险参与者功能结果转变的预测因子:来自 NEURAPRO 随机临床试验的结果。
Schizophr Res. 2019 Apr;206:67-74. doi: 10.1016/j.schres.2018.12.013. Epub 2018 Dec 14.
5
Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?首发精神病性发作前后的神经认知功能:精神病是否导致认知功能恶化?
Psychol Med. 2010 Oct;40(10):1599-606. doi: 10.1017/S0033291710000048. Epub 2010 Feb 5.
6
Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis.具有假定精神病前期状态和早期精神病的受试者的神经认知功能。
Schizophr Res. 2015 May;164(1-3):40-6. doi: 10.1016/j.schres.2015.03.006. Epub 2015 Mar 20.
7
Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia.精神病超高风险个体、精神病患者一级亲属及首发精神分裂症患者的认知功能。
Schizophr Res. 2016 Jul;174(1-3):71-76. doi: 10.1016/j.schres.2016.04.034. Epub 2016 May 16.
8
Do the same factors predict outcome in schizophrenia and non-schizophrenia syndromes after first-episode psychosis? A two-year follow-up study.首发精神病后,相同的因素是否能预测精神分裂症和非精神分裂症综合征的结局?一项为期两年的随访研究。
J Psychiatr Res. 2012 Jun;46(6):774-81. doi: 10.1016/j.jpsychires.2012.03.014. Epub 2012 Apr 7.
9
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].[一种用于评估精神分裂症认知功能的新工具的价值:精神分裂症认知功能简短评估量表(BACS)]
Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9.
10
Salivary cortisol in early psychosis: New findings and meta-analysis.早期精神病中的唾液皮质醇:新发现与荟萃分析。
Psychoneuroendocrinology. 2016 Jan;63:262-70. doi: 10.1016/j.psyneuen.2015.10.007. Epub 2015 Oct 16.

引用本文的文献

1
Effects of Physical Exercise on Executive Function in Schizophrenia: Systematic Review and Meta-Analysis.体育锻炼对精神分裂症执行功能的影响:系统评价与荟萃分析
Sports (Basel). 2025 Apr 16;13(4):123. doi: 10.3390/sports13040123.
2
Neurocognition in adolescents and young adults at clinical high risk for psychosis: Predictive stability for social and role functioning.青少年和年轻成人精神病高危人群的神经认知:社会和角色功能的预测稳定性。
Schizophr Res. 2024 Sep;271:129-137. doi: 10.1016/j.schres.2024.06.054. Epub 2024 Jul 17.
3
Association between homotopic connectivity and clinical symptoms in first-episode schizophrenia.
首发精神分裂症患者同伦连接性与临床症状之间的关联。
Heliyon. 2024 Apr 25;10(9):e30347. doi: 10.1016/j.heliyon.2024.e30347. eCollection 2024 May 15.
4
Effects of physical exercise on executive functions of individuals with schizophrenia spectrum disorders: Protocol for a systematic review and meta-analysis.运动对精神分裂谱系障碍个体执行功能的影响:系统评价和荟萃分析方案。
PLoS One. 2024 Jan 2;19(1):e0296273. doi: 10.1371/journal.pone.0296273. eCollection 2024.
5
Neurocognition and functioning in adolescents at clinical high risk for psychosis.临床高危精神病青少年的神经认知与功能
Child Adolesc Psychiatry Ment Health. 2023 Feb 8;17(1):22. doi: 10.1186/s13034-023-00567-1.
6
Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: Differences between males and females.首发非情感性精神病后临床和神经认知因素对心理社会功能的影响:男性与女性之间的差异
Front Psychiatry. 2022 Oct 20;13:982583. doi: 10.3389/fpsyt.2022.982583. eCollection 2022.
7
Positive symptoms of schizophrenia and their relationship with cognitive and emotional executive functions.精神分裂症的阳性症状及其与认知和情绪执行功能的关系。
Cogn Res Princ Implic. 2022 Aug 12;7(1):78. doi: 10.1186/s41235-022-00428-z.
8
The association of cognitive impairment with quality of life and functional impairment in Ugandan first-episode psychosis patients: a cross sectional study.认知障碍与乌干达首发精神病患者的生活质量和功能障碍的关系:一项横断面研究。
Health Qual Life Outcomes. 2022 Jul 23;20(1):113. doi: 10.1186/s12955-022-02020-x.
9
Comparison of two cognitive screening measures in a longitudinal sample of youth at-risk for psychosis.两种认知筛查措施在纵向风险精神分裂症青年样本中的比较。
Schizophr Res. 2022 Aug;246:216-224. doi: 10.1016/j.schres.2022.06.017. Epub 2022 Jul 7.
10
Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.未发展为精神病的临床精神病高危个体的临床结局:meta 分析。
Epidemiol Psychiatr Sci. 2022 Jan 19;31:e9. doi: 10.1017/S2045796021000639.